635 related articles for article (PubMed ID: 17499893)
1. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
2. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
Antonis AF; Claassen EA; Hensen EJ; de Groot RJ; de Groot-Mijnes JD; Schrijver RS; van der Most RG
Vaccine; 2006 Mar; 24(10):1551-61. PubMed ID: 16310293
[TBL] [Abstract][Full Text] [Related]
5. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
Mapletoft JW; Oumouna M; Townsend HG; Gomis S; Babiuk LA; van Drunen Littel-van den Hurk S
Virology; 2006 Sep; 353(2):316-23. PubMed ID: 16828832
[TBL] [Abstract][Full Text] [Related]
6. Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses.
Berghaus LJ; Corbeil LB; Berghaus RD; Kalina WV; Kimball RA; Gershwin LJ
Vaccine; 2006 Aug; 24(33-34):6018-27. PubMed ID: 16777273
[TBL] [Abstract][Full Text] [Related]
7. [Immunobiology of bovine respiratory syncytial virus infections].
Schrijver RS
Tijdschr Diergeneeskd; 1998 Nov; 123(22):658-62. PubMed ID: 9836385
[TBL] [Abstract][Full Text] [Related]
8. Bovine respiratory syncytial virus-specific immune responses in calves after inoculation with commercially available vaccines.
Ellis JA; Hassard LE; Morley PS
J Am Vet Med Assoc; 1995 Feb; 206(3):354-61. PubMed ID: 7751246
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
[TBL] [Abstract][Full Text] [Related]
10. Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.
Hägglund S; Hu KF; Larsen LE; Hakhverdyan M; Valarcher JF; Taylor G; Morein B; Belák S; Alenius S
Vaccine; 2004 Dec; 23(5):646-55. PubMed ID: 15542185
[TBL] [Abstract][Full Text] [Related]
11. Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
Kalina WV; Woolums AR; Gershwin LJ
Vaccine; 2005 Aug; 23(37):4625-30. PubMed ID: 15967545
[TBL] [Abstract][Full Text] [Related]
12. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
Ellis JA; Gow SP; Goji N
J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
[TBL] [Abstract][Full Text] [Related]
13. Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.
Olszewska W; Suezer Y; Sutter G; Openshaw PJ
Vaccine; 2004 Nov; 23(2):215-21. PubMed ID: 15531040
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.
Ellis JA; West KH; Waldner C; Rhodes C
Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518
[TBL] [Abstract][Full Text] [Related]
15. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV.
Vangeel I; Antonis AF; Fluess M; Riegler L; Peters AR; Harmeyer SS
Vet J; 2007 Nov; 174(3):627-35. PubMed ID: 17169592
[TBL] [Abstract][Full Text] [Related]
17. Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production.
Kalina WV; Anderson ML; Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):138-56. PubMed ID: 16644011
[TBL] [Abstract][Full Text] [Related]
18. Immunology of bovine respiratory syncytial virus infection of cattle.
Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2012 May; 35(3):253-7. PubMed ID: 22410266
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.
de Waal L; Wyatt LS; Yüksel S; van Amerongen G; Moss B; Niesters HG; Osterhaus AD; de Swart RL
Vaccine; 2004 Feb; 22(8):923-6. PubMed ID: 15161069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
